Advancing NK Cell Therapies & Engagers from Concept to Clinic

Driving Long Term Persistence, Clinical Efficacy & Scalability Across Autoimmunity & Oncology, to Spearhead an Investment Revival in NK Therapies for Patients in Need

The 11th Innate Killer Summit continues its legacy as the world’s leading industry meeting dedicated exclusively to advancing NK and innate immune cell therapies.

This year, the summit unites pioneering biotechs, including NKGen, NKILT, Senti Bio, NKore, and leaders from the MD Anderson Rizvani Lab, alongside translational scientists and platform innovators to showcase breakthrough progress in engineering, manufacturing, persistence, tumor targeting, and clinical translation.

As the NK space becomes increasingly competitive and the path to differentiation narrows, this summit stands firmly alongside the global NK community, providing the clarity, collaboration, and momentum needed to keep innovation moving forward.

With in-depth scientific content, real-world clinical insights across six clinical data updates, and unparalleled access to the full NK ecosystem, the 11th Innate Killer Summit remains the go-to meeting for those shaping the future of innate cell therapy. Now is the moment to align, connect, and act, as breakthroughs accelerate and the field enters a defining year for next-generation NK cell therapies.

What always stands out with the Innate Killer Summit are the more focused group discussions and a chance to speak to the decision makers over multiple sessions.

Director & Co-founder, East Ocyon Bio

East O Bio

Outstanding presentations and discussions focussed on NK biology and engineering were highly valuable to me as an NK researcher. It was a great opportunity to network with NK experts from around the country and the world.

Physician-Scientist Instructor, Stanford University

Stanford University

The topics were relevant and interesting/informative to anyone in the NK field. The conference size was small enough to connect with colleagues from other companies.

Chief Technical Officer, Artiva Biotherapeutics

Artiva

Explore the Agenda

  • 22+ Expert Speakers
  • 8+ Sessions of New Clinical Data
  • 3 days of Expert Content
  • 1 CEO Panel
  • The World’s Only Industry Forum Dedicated to NK Cell Therapies
brochure image

More than a Meeting ...

100+

Attendees

60%

C-Suite Speakers

6+

Hours of Networking

4

Expert Panel Discussions

2

Deep Dive Workshops

1

CEO Panel

Attending Companies Include

NKGen Biotec
NKILT Therapeutics
Senti Bio
GlycoStem
Artiva
NÖK Therapeutics
Immune Bridge
Panacea Venture
NKore
Alloplex Biotherapeutics
gecell therapeutics
MiNK Therapeutics
Lift Biosciences
Artec Biotech Inc
explore agenda image
Explore the Agenda

Discover the latest breakthroughs shaping NK and innate immune cell therapy in our expertly curated program. Gain actionable insights across engineering, manufacturing, persistence, and clinical development through data-rich presentations, collaborative roundtables, and brand-new strategic discussions built to tackle today’s biggest challenges in the NK space.

partner with us image
Partner With Us

Stand with the leaders driving the future of NK cell therapy. Position your brand at the heart of this legacy meeting and align with innovators seeking best-in-class tools, technologies, and partnerships. Showcase your solutions to the exact decision-makers shaping next-generation innate immune therapeutics.

join experts
Join Innate Immunity Experts

Connect with a highly engaged community of scientists, investors, academics and industry pioneers committed to advancing NK-based treatments. Be part of the most meaningful conversations in the field and build the relationships that will define the next wave of innovation in innate cell therapy.